Published online Feb 28, 2015. doi: 10.3748/wjg.v21.i8.2467
Peer-review started: August 17, 2014
First decision: September 15, 2014
Revised: September 29, 2014
Accepted: December 8, 2014
Article in press: December 8, 2014
Published online: February 28, 2015
Processing time: 196 Days and 18 Hours
AIM: To investigate the efficacy and safety of percutaneous needle decompression in the treatment of malignant small bowel obstruction (MSBO).
METHODS: A prospective analysis of the clinical data of 52 MSBO patients undergoing percutaneous needle decompression was performed.
RESULTS: Percutaneous needle decompression was successful in all 52 patients. Statistically significant differences were observed in symptoms such as vomiting, abdominal distension and abdominal pain before and after treatment (81.6% vs 26.5%, 100% vs 8.2%, and 85.7% vs 46.9%, respectively; all P < 0.05). The overall significantly improved rate was 19.2% (11/52) and the response rate was 94.2% (49/52) using decompression combined with nasal tube placement, local arterial infusion of chemotherapy and nutritional support. During the one-month follow-up period, puncture-related complications were acceptable.
CONCLUSION: Percutaneous needle intestinal decompression is a safe and effective palliative treatment for MSBO.
Core tip: Malignant small bowel obstruction (MSBO) is a common complication in patients with advanced cancer. In this study, we prospectively analyzed MSBO patients undergoing percutaneous needle decompression in our hospital over the past few years to identify the value of this technique in the palliative treatment of MSBO. We concluded that percutaneous needle intestinal decompression is a safe and effective palliative treatment for MSBO. When combined with local arterial infusion of chemotherapy and nasal intestinal decompression tube placement, percutaneous needle decompression can further improve the clinical remission.